ACE & Company, a Geneva, Switzerland-based global investment firm, closed its fourth private equity co-investment fund, at $244m.
Kingstone Schweizer Ventures (KSV), a Dusseldorf, Germany and Zurich, Switzerland-based family office joint venture solving humanity’s inheritable crises with creativity, capital and technology, officially launched.
Merck KGaA, a global science and technology company which operates across healthcare, life science and electronics, acquired Chord Therapeutics, a Geneva, Switzerland-based clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases.
Cube RM, a Zurich, Switzerland-based AI tender management platform helping enterprises discover, bid for and win tenders globally, raised $8m in Series A funding.
Eos Venture Partners, a London, UK-based InsurTech Venture Capital fund manager, and Twelve Capital, a Zürich, Switzerland-based investment manager specialising in the insurance industry, have teamed up to provide growth funding for InsurTech companies.
Adcubum AG, a Swiss health and property & casualty (P&C) insurance software provider, received a strategic growth investment from TA Associates, a global growth private equity firm.
MTIP, a Basel, Switzerland-based healthtech focused private equity firm, closed MTIP Fund II, SCSp, at USD $250m.
Origyn Foundation, a Neuchâtel, Switzerland-based nonprofit dedicated to identifying, authenticating and unlocking the powers of ownership for objects of value, raised $20m in funding.
Vifor Pharma, a St. Gallen, Switzerland-based global pharma company, is to acquire Inositec AG, a Zurich Switzerland-based developing first-in-class non-dialysis treatments for soft tissue and vascular calcification disorders.
Aktiia, a Neuchatel, Switzerland-based developer of a wearable blood-pressure monitoring system, raised $17.5M in Series A funding.
Yokoy, a Zurich, Switzerland-based provider of a spend management platform, raised $26M in Series A funding.
Evolution Equity Partners, a global venture capital firm, closed a new fund, at $400m.
SkyCell, a Swiss pharma-tech company manufacturing smart containers enabling the safe, secure, and sustainable transportation of pharmaceutical products, raised $34.8m (CHF 32m) in Series C funding.
Pictet Alternative Advisors (PAA), the alternative investment specialist of Geneva, Switzerland-based Pictet Group closed its debut thematic private equity fund focused on technology at USD 350m.
Open Mineral, a Zug, Switzerland-based mining technology company, raised $33m in Series C funding.